Skip to main content

Table 2 Plasma pharmacokinetic parameters of MCHB and CNOB in mice carrying 4T1/HchrR6 tumors. Plasma samples were collected at various times (5 min, 15 min, 30 min, 1 h, 2 h, 4 h, 6 h, 12 h, and 24 h) after iv dose of CNOB in nude mice carrying 4T1/HchrR6 tumors. MCHB and CNOB levels overtime were determined by LC/MS/MS

From: Utilizing native fluorescence imaging, modeling and simulation to examine pharmacokinetics and therapeutic regimen of a novel anticancer prodrug

CNOB Dose

Analyte

Cmax ± SE

AUC0-24 ± SE

Vss

CL

t1/2

mg/kg

 

ng/mL

h*ng/mL

L/kg

L/h/kg

h

3.3

CNOB

141 ± 28.6

166 ± 23.5

81.5

17.7

4.6

 

MCHB

145 ± 30.4

148 ± 16.0

117

21.1

8.3

  1. C max maximum observed concentration ± standard error (SE), AUC 0-24 area under the concentration curve from 0 to 24 h ± SE, V ss volume of distribution, CL clearance; t 1/2 terminal elimination half-life